Prevention of mother-to-child transmission of hepatitis B: birth-dose vaccination is not enough.

Lancet Glob Health

Expanded Program on Immunization, Ministry of Public Health, Yaoundé, Cameroon.

Published: April 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2214-109X(22)00046-8DOI Listing

Publication Analysis

Top Keywords

prevention mother-to-child
4
mother-to-child transmission
4
transmission hepatitis
4
hepatitis birth-dose
4
birth-dose vaccination
4
prevention
1
transmission
1
hepatitis
1
birth-dose
1
vaccination
1

Similar Publications

Background: Antiretroviral drugs are essential for preventing mother-to-child transmission (MTCT) of HIV in HIV-infected pregnant women. However, ART treatment for HIV-infected pregnant women with multidrug resistance remains a major challenge. Effective and safe ART regimens for preventing MTCT should be tailored to this special population.

View Article and Find Full Text PDF

There is little research on anemia and vitamin D deficiency in HIV-exposed uninfected (HEU) children. This study was aimed to describe and compare the prevalence of anemia and vitamin D inadequacy in HEU children and HIV-unexposed uninfected (HUU) children, and to examine the associations of HIV exposure with anemia and vitamin D inadequacy. This was a hospital-based descriptive cross-sectional study nested within the Prevention of Mother-to-Child Transmission (PMTCT) of HIV program in Hunan Province during July and September 2022.

View Article and Find Full Text PDF

Background: HIV is a major public health issue in South Africa, with around 7.7 million people living with the virus by 2023, including 4.9 million women.

View Article and Find Full Text PDF

Introduction: Effective prevention of mother to child transmission (PMTCT) programmes require women and their infants to have access to a cascade of HIV care and treatment interventions. Retention in care reduces the risk of vertical transmission and opportunistic infections among mothers living with HIV. Uganda has made great strides in ensuring the success of the prevention of mother to child transmission program.

View Article and Find Full Text PDF

Objectives: To evaluate the impact of a comprehensive intervention using nursing-sensitive quality indicators on pregnant women with hepatitis B and their newborns.

Design: A randomized controlled monocentric trial conducted from January 2020 to May 2022. Participants/Materials: 80 pregnant women diagnosed with hepatitis B were randomly assigned to either a control group (n=40) or an experimental group (n=40).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!